Jonathan Peacock

2015

In 2015, Jonathan Peacock earned a total compensation of $1.2M as former Chief Executive Officer at Bellerophon Therapeutics, a 76% decrease compared to previous year.

Compensation breakdown

Bonus$400,000
Option Awards$356,534
Salary$400,000
Stock Awards$13,278
Other$11,215
Total$1,181,027

Peacock received $400K in bonus, accounting for 34% of the total pay in 2015.

Peacock also received $356.5K in option awards, $400K in salary, $13.3K in stock awards and $11.2K in other compensation.

Rankings

In 2015, Jonathan Peacock's compensation ranked 7,125th out of 13,638 executives tracked by ExecPay. In other words, Peacock earned more than 47.8% of executives.

ClassificationRankingPercentile
All
7,125
out of 13,638
48th
Division
Manufacturing
2,688
out of 5,190
48th
Major group
Chemicals And Allied Products
967
out of 1,854
48th
Industry group
Drugs
776
out of 1,528
49th
Industry
Pharmaceutical Preparations
605
out of 1,182
49th
Source: SEC filing on March 20, 2017.

Peacock's colleagues

We found five more compensation records of executives who worked with Jonathan Peacock at Bellerophon Therapeutics in 2015.

2015

Martin Meglasson

Bellerophon Therapeutics

Chief Scientific Officer

2015

Deborah Quinn

Bellerophon Therapeutics

Chief Medical Officer

2015

Reinilde Heyrman

Bellerophon Therapeutics

former Chief Clinical Development Officer

2015

Martin Dekker

Bellerophon Therapeutics

Vice President of Device Engineering and Manufacturing

2015

Peter Fernandes

Bellerophon Therapeutics

Chief Regulatory and Safety Officer

You may also like